 BEVERLY, Mass., June 29, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., OTCQB: LXXGF; TSX-V: LXG the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that the Company filed their Annual Information Form and its financial results for the fourth quarter and year end February 28, 2021. 